Verition Fund Management’s Cellebrite CLBT Stock Holding History

Verition Fund Management’s Portfolio CLBT Stock Details CLBT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.77M	Sell	190,000 -68,781	-27%	-$909K	0.01%	943
2026 Q1	$3.57M	Buy	258,781 +217,481	+527%	+$3.28M	0.02%	727
2025 Q4	$745K	Hold	41,300	–	–	﹤0.01%	2373
2025 Q3	$765K	Sell	41,300 -670	-2%	-$10.5K	﹤0.01%	2730
2025 Q2	$672K	Buy	41,970 +320	+0.8%	+$5.71K	﹤0.01%	2751
2025 Q1	$809K	Sell	41,650 -44,793	-52%	-$943K	﹤0.01%	2279
2024 Q4	$1.9M	Sell	86,443 -23,816	-22%	-$458K	0.01%	1582
2024 Q3	$1.86M	Buy	110,259 +18,859	+21%	+$280K	0.01%	1467
2024 Q2	$1.09M	Buy	91,400 +8,137	+10%	+$90.9K	0.01%	1621
2024 Q1	$923K	Buy	83,263 +43,369	+109%	+$443K	0.01%	1667
2023 Q4	$345K	Sell	39,894 -2,409	-6%	-$18.7K	﹤0.01%	1724
2023 Q3	$324K	Buy	42,303 +32,045	+312%	+$241K	﹤0.01%	1683
2023 Q2	$73.9K	Buy	+10,258	New	+$59.8K	﹤0.01%	2009

Other funds holding CLBT

TWCM

True Wind Capital Management San Francisco, California $226M AUM 2.79% 1-Year Est. Return

Voss Capital Houston, Texas $2.15B AUM 33.46% 1-Year Est. Return

Pertento Partners London, United Kingdom $1.86B AUM 53.86% 1-Year Est. Return

Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

NTCM

Nine Ten Capital Management Chicago, Illinois $321M AUM 44.58% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return

Verition Fund Management's CLBT Position: Q2 2026 in Review

Verition Fund Management reduced its Cellebrite (CLBT) stake by 27% in Q2 2026, selling an estimated $909K and leaving 190,000 shares worth $2.77M. The position accounts for 0.01% of the portfolio, ranked #943.

Verition Fund Management first reported a position in CLBT in Q2 2023 and has held it in 13 quarters since. The position peaked at $3.57M in Q1 2026. 201 funds tracked by Wall St. Rank hold CLBT as of Q2 2026.

Verition Fund Management held 190,000 shares of Cellebrite worth $2.77M as of Q2 2026.
Verition Fund Management sold 68,781 Cellebrite shares in Q2 2026, an estimated $909K.
Cellebrite made up 0.01% of Verition Fund Management's portfolio in Q2 2026, its #943 holding.
Verition Fund Management first reported a position in Cellebrite in Q2 2023 and has held it in 13 quarters since.
Verition Fund Management's Cellebrite position peaked at $3.57M in Q1 2026.
201 funds tracked by Wall St. Rank held Cellebrite as of Q2 2026.

Based on Verition Fund Management's 13F filing for Q2 2026, filed 14 Aug 2026.